Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study Meeting Abstract
| Authors: | Coleman, R.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; Harter, P.; Murphy, C.; Esteves, B.; Method, M.; Lorusso, D.; Matulonis, U. |
| Abstract Title: | Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Evaluation of sequence of therapy on anti-tumor activity in the SORAYA study |
| Meeting Title: | Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer (54th Annual Meeting) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 176 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Mar 25-28 |
| Meeting Location: | Tampa, FL |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S3 |
| Language: | English |
| ACCESSION: | WOS:001079556100005 |
| DOI: | 10.1016/j.ygyno.2023.06.468 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 002 -- Source: Wos |
